On July 9, Texas Instruments rose 3.95% in pre-market trading, trading at $313.0/share, with turnover of $1.9953 million.

On the news front, multiple investment banks have recently raised their target prices for Texas Instruments in rapid succession. Cantor Fitzgerald on July 8 raised its target price from $300 to $340, following UBS's upgrade to $350, STIFEL's increase to $360, and Citi's adjustment from $280 to $345, all maintaining buy or overweight ratings. Citi analysts highlighted that Texas Instruments is expected to gain upside from supplying power management chips to NVIDIA in the second half, identifying it as a name with upward catalysts. According to FactSet, the average analyst rating stands at overweight with a mean target price of $301.43.

Additionally, Singapore's Competition and Consumer Commission is currently assessing Texas Instruments' proposed acquisition of Silicon Laboratories, with the public input deadline set for July 22. The company's next earnings report is scheduled for July 22, with consensus EPS expectations of $1.90.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)